Supplier News

The latest developments from suppliers of ingredients, development and manufacturing services, and related technologies for pharmaceutical and biopharmaceutical development and production.

The latest from CDMOs/CMOs and suppliers in COVID-19 projects featuring Rovi, Eurofins, and SiO2 Materials Science. Formulation Development/Drug-Product Manufacturing Rovi To Fill–Finish Moderna’s COVID-19 Vaccine Candidate Laboratorios...

The latest from CDMOs/CMOs and suppliers in COVID-19 projects featuring Catalent and Stevanato Group. Formulation Development-Drug Product Manufacturing Catalent, Moderna Enter Pact for Fill–Finish of COVID-19 Vaccine Catalent and Moderna, a...

Grand River Aseptic Manufacturing (GRAM), a Grand Rapids, Michigan-based provider of sterile-manufacturing services, has completed a $60-million expansion project with the opening of a large-scale fill–finish facility in Grand Rapids,...

The latest from CDMOs/CMOs and suppliers in COVID-19 projects featuring Catalent and Symbiosis Pharmaceutical Services. Biologics Manufacturing Catalent, ViralClear Enter Pact for Potential COVID-19 Treatment Catalent has signed an agreement with...

Cambrex, a CDMO of small-molecule active pharmaceutical ingredients and drug products, has named Thomas Loewald as the company’s new Chief Executive Officer (CEO) and a member of the company’s Board of Directors, effective September 7, 2020. He is...

The latest from CDMOs/CMOs and suppliers in COVID-19 projects featuring Catalent, Emergent BioSolutions, AGC Biologics, Cobra Biologics, Jacobs Engineering, and Cascade Chemistry. Chemical/Chemical API Manufacturing Cascade Chemistry To Produce...

Lonza has named Pierre-Alain Ruffieux as the company’s new Chief Executive Officer (CEO), effective November 1, 2020. He is currently Head of Global Pharma Technical Operations at Roche where leads a 12,000-member team responsible for...